Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3045297

NC1CC1c1cccc(F)c1.O=C(O)C(F)(F)F

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 14/20 0.51
MAOB P27338 10/20 0.51
MAOA P21397 12/20 0.48
HTR2C P28335 2/20 0.48
HTR2A P28223 1/20 0.48
HTR2B P41595 1/20 0.48
KDM4E B2RXH2 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
CYP2C19 P33261 4/20 0.46
CYP2B6 P20813 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 2/20 0.46
LMNA P02545 1/20 0.46
CYP3A4 P08684 1/20 0.46
HTR1A P08908 1/20 0.46
ADRA2A P08913 1/20 0.46
CYP2A6 P11509 1/20 0.46
SLC6A2 P23975 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3422301 0.85 HTR2C (0.61) KDM1AMAOBMAOAHTR2CHTR2A
SCHEMBL3419759 0.85 HTR2C (0.61) KDM1AMAOBMAOAHTR2CHTR2A
SCHEMBL3031647 0.85 HTR2C (0.61) KDM1AMAOBMAOAHTR2CHTR2A
SCHEMBL6998583 0.85 HTR2C (0.61) KDM1AMAOBMAOAHTR2CHTR2A
(+)-Tranylcypromine SCHEMBL15541916 0.84 MAOB (0.67) KDM1AMAOBMAOAHTR2CKDM4E
Trifluoroacetic Acid SCHEMBL15541698 0.84 SLC9A1 (0.50) KDM1AMAOBMAOAHTR2CHTR2A
Trifluoroacetic Acid SCHEMBL15541699 0.84 SLC9A1 (0.50) KDM1AMAOBMAOAHTR2CHTR2A
Trifluoroacetic Acid SCHEMBL15540595 0.79 KDM1A (0.54) KDM1AHTR2CHTR2AHTR2BKCNH2
Trifluoroacetic Acid SCHEMBL30423767 0.76 SLC9A1 (0.46) KDM1AMAOBMAOAHTR2CHTR2A
Trifluoroacetic Acid SCHEMBL27838178 0.75 KDM1A (0.40) KDM1AHTR2CHTR2AHTR2BCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8299100-B2 Potent and selective neuronal nitric oxide synthase inhibitors with improved membrane permeability NORTHWESTERN UNIVERSITY (US) 2012-10-30 US disclosed
US-20100190230-A1 Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors with Improved Membrane Permeability NORTHWESTERN UNIVERSITY 2010-07-29 US disclosed
WO-2010085749-A2 POTENT AND SELECTIVE NEURONAL NITRIC OXIDE SYNTHASE INHIBITORS WITH IMPROVED MEMBRANE PERMEABILITY NORTHWESTERN UNIVERSITY (US) 2010-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190230-A1 Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors with Improved Membrane Permeability NOS1, NOS2, NOS3 KDM1A 2593/4885MAOB 95/4885MAOA 109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.